Citation Impact
Citing Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
2007 Standout
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
2011 Standout
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
2010
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
2011 Standout
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Gastric cancer
2016 Standout
Mechanisms of Thrombus Formation
2008 Standout
Synthesis of Biomolecule‐Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells
2011 StandoutNobel
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Docetaxel 75 mg/m2 is Active and Well Tolerated in Patients with Metastatic or Recurrent Gastric Cancer: a Phase II Trial
2002
Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials
2013
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters
2009
Gold nanoparticles in delivery applications☆
2008 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Targeted treatments in colorectal cancer: state of the art and future perspectives
2010
Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy
2015
Pancreatic cancer
2016 Standout
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
2011
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Colorectal cancer
2013 Standout
IgG4-Related Disease
2012 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Colorectal cancer
2019 Standout
Antibody therapy of cancer
2012 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
IgG4 breaking the rules
2002
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Adjuvant Therapy of Stage II and III Colon Cancer
2005
Oesophageal carcinoma
2013 Standout
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Adjuvant Therapy for Colon Cancer 2005: New Options in the Twenty-First Century
2006
Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial
2012
Redox Control of Exofacial Protein Thiols/Disulfides by Protein Disulfide Isomerase
1999
CD26, let it cut or cut it down
1999
Prevention of Venous Thromboembolism
2004 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
2013 StandoutNature
Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in action
2013
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Understanding resistance to EGFR inhibitors—impact on future treatment strategies
2010
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Gastric cancer
2020 Standout
Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide
1999
Colorectal cancer
2005
Prevention of Venous Thromboembolism
2008 Standout
IgG4-related disease
2014 Standout
Pancreatic Cancer
2010 Standout
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
Treatment of Acute Lymphoblastic Leukaemia
2007
Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study
2002
Physical Proximity and Functional Association of Glycoprotein 1bα and Protein-disulfide Isomerase on the Platelet Plasma Membrane
2000
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects
2012
Current Issues in Adjuvant Treatment of Stage II Colon Cancer
2006
Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies
2010
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Structure and function of “metalloantibiotics”
2003
The multifunctional or moonlighting protein CD26/DPPIV
2003
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters
2007
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells
2013
Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities
2003
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second‐line therapy for patients with advanced pancreatic cancer
2008
Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV
2003
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
2009 Standout
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
2006 Standout
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer
2007
Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies
2011
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
A multi-center, late phase II clinical trial of Genexol® (paclitaxel) and cisplatin for patients with advanced gastric cancer
2004
Phase II Multi-Institutional Randomized Trial of Docetaxel Plus Cisplatin With or Without Fluorouracil in Patients With Untreated, Advanced Gastric, or Gastroesophageal Adenocarcinoma
2005
Impact of FcγRIIa-FcγRIIIa Polymorphisms and KRAS Mutations on the Clinical Outcome of Patients With Metastatic Colorectal Cancer Treated With Cetuximab Plus Irinotecan
2009
Evolving Treatment of Advanced Colon Cancer
2009
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
2014 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
A cell nanoinjector based on carbon nanotubes
2007 StandoutNobel
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
2010
Works of H. Kröning being referenced
Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial
2007
Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer
2001
Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial
2005
High reliability and sensitivity of the BCR/ABL1 D-FISH test for the detection of BCR/ABL rearrangements
2002
Thiol‐Proteindisulfide–Oxidoreductase (Proteindisulfide Isomerase): a New Plasma Membrane Constituent of Mature Human B Lymphocytes
1994
Phase I/II Dose-Escalation Study of Pemetrexed plus Irinotecan in Patients with Advanced Colorectal Cancer
2005
Alterations in Structure and Cellular Localization of Molecular Forms of DP IV/CD26 during T Cell Activation
1996
Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial
2004
Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells.
1997
Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial
2004
IMPACT study: A phase II-III clinical study with the immunomodulator MGN1703 in patients with advanced colorectal carcincoma.
2012
EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer
2008